α-Tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism

Circulation

Volumn 94, Issue 10, 1996, Pages 2434-2440

  Freedman, Jane E ^a   Farhat, John H ^a   Loscalzo, Joseph ^a   Keaney Jr , John F ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antioxidants; coronary disease; platelet aggregation inhibitors; platelets; thrombosis; vitamins

Indexed keywords

ALPHA TOCOPHEROL; PROTEIN KINASE C;

ARTICLE; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; HUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0029846809     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.10.2434     Document Type: Article

References (43)

1. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450-1456.
2. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett W. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
3. Stephens NG, Parsons A, Schofield PM, Kelly F, Sheesman K, Mitchmson MJ, Brown MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781-786.
4. Keaney JF Jr, Frei B, Antioxidant protection of low-density lipoprotein and its role in the prevention of atherosclerotic vascular disease. In: Frei B, ed. Natural Antioxidants in Human Health and Disease. San Diego, Calif: Academic Press; 1994:303-352.
5. Dieber-Rotheneder M, Puhl H, Waeg H, Striegl G, Esterbauer H. Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res. 1991;32:1325-1332.
6. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
7. Keaney JF Jr, Gaziano JM, Xu A, Frei B, Curran-Celentano J, Shwaery GT, Loscalzo J, Vita JA. Low-dose α-tocopherol improves and high-dose α-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest. 1994;93:844-851.
8. Kleinveld HA, Demacker PNM, Stalenhoef AFH. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb. 1994; 14:1386-1391.
9. Keaney JF Jr, Gaziano JM, Xu A, Frei B, Curran-Celantano J, Shwaery GT, Loscalzo J, Vita JA. Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc Natl Acad Sci USA. 1993;90:11880-11884.
10. Stewart-Lee AL, Forster LA, Nourooz-Zadeh J, Ferns GAA, Änggård EE. Vitamin E protects against impairment of endothelium-mediated relaxations in cholesterol-fed rabbits. Arterioscler Thromb. 1994; 14:494-499.
11. Nègre-Salvayre A, Alomar Y, Troly M, Salvayre R. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells, III: the protective effect of antioxidants (probucol, catechin, vitamin E) against the cytotoxicity of oxidized LDL occurs on two different ways. Biochim Biophys Acta. 1991;1096: 291-300.
12. Steiner M, Anastasi J. Vitamin E: an inhibitor of the platelet release reaction. J Clin Invest. 1976;57:732-737.
13. Agradi E, Petroni A, Socini A, Galli C. In vitro effects of synthetic antioxidants and vitamin E on arachidonic acid metabolism and thromboxane formation in human platelets and on platelet aggregation. Prostaglandins. 1981;22:255-266.
14. Srivasta KC. Vitamin E exerts antiaggregatory effects without inhibiting the enzymes of the arachidonic acid cascade in platelets. Prostaglandins Leukot Med. 1986;21:177-201.
15. Cox AC, Rao GHR, Gerrard JM, White JG. The influence of α-tocopherol quinone on platelet structure, function and biochemistry. Blood. 1980;55:907-914.
16. Steiner M. Effect of α-tocopherol administration on platelet function in man. Thromb Haemost. 1983;49:73-77.
17. Jandak J, Steiner M, Richardson PD. Alpha-tocopherol, an effective inhibitor of platelet ahesion. Blood. 1989;73:141-149.
18. The Alpha-Tocopherol Beta-Carotene Cooperative Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330: 1029-1035.
19. Budavari S. ed. The Merck Index. 11th ed. Rahway, NJ: Merck and Co; 1989:1529-1530.
20. Freedman JE, Loscalzo J, Benoit SE, Valeri CR, Barnard MR, Michelson AD. Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J Clin Invest. 1996; 97:979-987.
21. Keaney JF Jr, Xu A, Cunningham D, Jackson T, Frei B, Vita JA. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and Superoxide generation. J Clin Invest. 1995;95:2520-2529.
22. Rais S, Combadiere C, Hakin J, Perianin A. Staurosporine up-regulates the expression of phorbol dibutyrate binding sites in human platelets. Biochem Pharmacol. 1994;47:1797-1804.
23. Grabarek J, Ware JA. Protein kinase C activation without membrane contact in platelets stimulated by byrostatin. J Biol Chem. 1993; 268:5544-5549.
24. Kahl R, Winke S, Kappus H. Comparison of antioxidant and prooxidant activity of various synthetic antioxidants. Adv Exp Med Biol. 1990;264:283-290.
25. Packham MA, Livne A-A, Ruben DH, Rand ML. Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine, and okadaic acid. Biochem J. 1993;290:849-856.
26. Boscoboinik D, Szewczyk A, Hensey C, Azzi A. Inhibition of cell proliferation by α-tocopherol. J Biol Chem. 1991;266:6188-6194.
27. Higashi O, Kikuchi Y. Effects of vitamin E on the aggregation and the lipid peroxidation of platelets exposed to hydrogen peroxide. Tohoku J Exp Med. 1974;112:271-278.
28. Princen HM, van Poppel G, Vogelezang C, Buytenhek R, Kok FJ. Supplementation with vitamin E but not beta carotene in vivo protects low-density lipoprotein from lipid peroxidation in vitro: effect of cigarette smoking. Arterioscler Thromb. 1992;12:554-562.
29. Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum JL. Effect of dietary antioxidant combinations in humans: protection of LDL by vitamin E but not beta carotene. Arterioscler Thromb. 1993;13:590-600.
30. Traber MG. Determinants of plasma vitamin E concentrations. Free Radic Biol Med. 1994;16:229-239.
31. Kostner GM, Oettl K, Juahiainen M, Ehnholm C, Esterbauer H, Dieplinger H. Human plasma phospholipid transfer protein accelerates exchange/transfer of α-tocopherol between lipoproteins and cells, Biochem J. 1995;305:659-667.
32. Murer EH. Release reaction and energy metabolism in blood platelets with special reference to the burst in oxygen uptake. Biochim Biophys Acta. 1968;162:320-326.
33. Okuma M, Steiner M, Bladini MG. Studies in lipid peroxides in platelets, II: effect of aggregating agents and platelet antibody. J Lab Clin Med. 1971;77:728-742.
34. Hemler ME, Lands WEM. Evidence for a peroxide-initiated free radical mechanism of prostaglandin biosynthesis. J Biol Chem. 1980; 225:6253-6260.
35. Kockman V, Vericel E, Croset M, Lagade M. Vitamin E fails to alter the aggregation and oxygenated metabolism of arachidonic acid in normal human platelets. Prostaglandins. 1988;36:607-620.
36. Ali M, Budbranson CG, McDonald JWD. Inhibition of human platelet cyclooxygenase by α-tocopherol. Prostaglandins Leukot Med. 1980;4:79-85.
37. Mower R, Steiner M. Biochemical interaction of arachidonic acid and vitamin E in human platelets. Prostaglandins Leukot Med. 1983;10:389-403.
38. Seeger W, Moser U, Roka L. Effects of alpha-tocopherol, its carboxylic acid chromane compound and two novel antioxidant isoflavanones on prostaglandin H synthase activity and autodeactivation. Naunyn Schmiedebergs Arch Pharmacol. 1988;338: 74-81.
39. Srivastava KC. Vitamin E exerts antiaggregatory effects without inhibiting the enzymes of the arachidonic acid cascade in platelets. Prostaglandins Leukot Med. 1986;21:177-182.
40. Mower R, Steiner M. Synthetic byproducts of tocopherol oxidation as inhibitors of platelet function. Prostaglandins. 1982;24:137-147.
41. Kroll MH, Hellums JD, Guo Z, Durante W, Razdan D, Hrbolich JK, Schafer AI. Protein kinase C is activated in platelets subjected to pathological shear stress. J Biol Chem. 1993;268:3520-3524.
42. Roth GJ. Developing relationships: arterial platelet adhesion, glycoprotein Ib, and leucine-rich glycoproteins. Blood. 1991;77:5-19.
43. Chatelain E, Boscoboinik DO, Bartoli GM, Kagan VE, Geiy FK, Packer L, Azzi A. Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochim Biophys Acta. 1993;1176:83-89.